Supported by the NIHR (NIHR Evaluation, Health Technology Assessment Programme; funder number, 12/127/157). We thank all the SIMS trial patients without whom this trial would not have been possible; the members of the independent trial steering committee (Chris Mayne [chair], Isobel Montgomery, Dudley Robinson, Lynda Harper, Eleanor Mitchell, and Khaled Ismail) for their supervision of the trial and their guidance and support; the members of the independent data monitoring committee (Peter Brocklehurst [chair], Lee Middleton, Christian Phillips, and Doug Tincello) for their work in assessing all serious adverse events reported to the trial office in real time; Phil Assassa for his substantive role in the trial, including the obtaining of funding, the design of the protocol, and the recruitment of patients; Athele Khunda for his role in patient recruitment and for his contribution to the trial; and Ahmed Mansor and Katie Gillespie for their contribution with the systematic review.
Peer reviewed
Postprint